Koulaouzidis George, Tsigkriki Lamprini, Grammenos Orestis, Iliopoulou Sotiria, Kalaitzoglou Maria, Theodorou Panagiotis, Bostanitis Ioannis, Skonieczna-Żydecka Karolina, Charisopoulou Dafni
Department of Biochemical Sciences, Pomeranian Medical University, 70-204 Szczecin, Poland.
Cardiology Department, General Hospital G. Papanikolaou, 57010 Thessaloniki, Greece.
Clin Pract. 2025 Apr 10;15(4):79. doi: 10.3390/clinpract15040079.
Telemedicine (TM) has emerged as a promising tool for improving heart failure (HF) management by allowing non-invasive, remote patient monitoring. However, patient adherence to TM plays a critical role in its effectiveness. This systematic review aims to assess adherence levels to non-invasive TM interventions and explore factors influencing compliance. This systematic review followed the PRISMA guidelines. A literature search was conducted across the PubMed, Medline, Web of Science, and Google Scholar databases to identify prospective randomized controlled trials published between January 2010 and June 2024. The inclusion criteria included studies focused on non-invasive TM in HF patients with a follow-up period longer than three months. Adherence rates were categorized as high (≥80%), moderate (60-79%), or low (<60%). Of the 136 identified studies, 6 met the inclusion criteria. Three studies reported high adherence (>80%), and three moderate adherence (60-79%). Older patients (≥65 years) showed higher adherence, with two studies exceeding 85% adherence. Studies with higher female participation (>30%) reported better adherence, with two exceeding 88%. Across studies, a lack of racial diversity was especially notable, apart from a study that included a population with 69% black and 31% Hispanic participants, where adherence was 50% for ≥10 uploads over a 90-day period. Seasonal variations affected adherence, with December being the lowest (47-69%) and August the highest (>85%). Monitoring multiple health parameters correlated with better adherence (>85%) compared to single-parameter tracking (50-74%). TM is a promising tool for HF management, but adherence differs by age, sex, and the complexity of monitoring. To optimize TM use, standardized adherence measures and tailored strategies are needed.
远程医疗(TM)已成为一种有前景的工具,可通过无创远程患者监测来改善心力衰竭(HF)管理。然而,患者对远程医疗的依从性对其有效性起着关键作用。本系统评价旨在评估对无创远程医疗干预措施的依从水平,并探讨影响依从性的因素。本系统评价遵循PRISMA指南。在PubMed、Medline、科学网和谷歌学术数据库中进行文献检索,以识别2010年1月至2024年6月期间发表的前瞻性随机对照试验。纳入标准包括针对心力衰竭患者的无创远程医疗且随访期超过三个月的研究。依从率分为高(≥80%)、中(60 - 79%)或低(<60%)。在136项已识别的研究中,6项符合纳入标准。三项研究报告高依从性(>80%),三项报告中等依从性(60 - 79%)。老年患者(≥65岁)显示出更高的依从性,两项研究的依从性超过85%。女性参与度较高(>30%)的研究报告依从性更好,两项超过88%。在各项研究中,种族多样性不足尤为显著,除了一项纳入69%为黑人、31%为西班牙裔参与者的研究,该研究中90天内≥10次上传的依从性为50%。季节变化影响依从性,12月最低(47 - 69%),8月最高(>85%)。与单参数跟踪(50 - 74%)相比,监测多个健康参数与更好的依从性(>85%)相关。远程医疗是心力衰竭管理的一种有前景的工具,但依从性因年龄、性别和监测复杂性而异。为优化远程医疗的使用,需要标准化的依从性措施和量身定制的策略。